June 25, 2014
11:00 am to 12:00 pm EDT

Sponsored by

Webinar Description:

A rapid, accurate, and inexpensive tuberculosis (TB) diagnostic test in the developing world would allow earlier treatment and reduce transmission. The highly multiplexed proteomic SOMAscan assay was applied to measure 1129 human proteins and 16 M. tuberculosis proteins in serum and urine samples from diverse geographic origins for protein marker identification and model building, followed by verification of the TB biosignature in a blinded sample set. In this webinar, strategies to use measurements of host and pathogen markers in multiple matrices to gain insights into pathogenesis and to obtain useful biosignatures for diagnostics, prognostics and therapeutic monitoring will be discussed.

Learning Objectives:

• Importance of Sample Diversity in Biomarker Discovery
• Modeling Strategies
• Optimization of Test Performance

Speaker Information

Urs Ochsner, PhD, Associate Director, Technology Development, SomaLogic, Inc.

Urs Ochsner is the head of Infectious Disease research at SomaLogic, Inc., a biomarker discovery and clinical diagnostics company based in Boulder, Colorado. Dr. Ochsner received his PhD in Biotechnology at the Swiss Federal Institute of Technology in Zurich. As a postdoctoral fellow and instructor at the University of Colorado Health Sciences Center he studied bacterial pathogenesis and host response, before joining the biotech industry focusing on antibacterial drug development and diagnostics. Dr. Ochsner has published over 50 peer-reviewed articles and several book chapters.

Cost: No cost